Related Experiment Videos
Sedation in acute and chronic agitation
1New York University School of Medicine, New York 10016, USA.
Pharmacotherapy
|November 1, 1996
Summary
Managing agitation in psychiatric disorders requires individualized treatment. Initial goals focus on sedation and control, transitioning to long-term strategies that minimize sedation for optimal patient function.
Area of Science:
- Psychiatry
- Pharmacology
Background:
- Agitation is a common, nonspecific symptom across various psychiatric conditions, including schizophrenia and organic behavioral disturbances.
- Effective treatment necessitates an individualized approach based on the specific cause of psychomotor disturbance.
Purpose of the Study:
- To review the pharmacological management of acute agitation.
- To discuss the evolution of treatment strategies from older sedatives to modern antipsychotics and benzodiazepines.
- To outline approaches for minimizing sedation during long-term treatment.
Main Methods:
- Review of pharmacological agents used for agitation management.
- Comparison of historical and current treatment modalities.
- Analysis of treatment goals during acute and long-term phases.
Main Results:
- Initial management of acute agitation prioritizes sedation and control of disruptive behavior.
- Higher-potency antipsychotics and benzodiazepines have largely replaced older agents like barbiturates and chlorpromazine.
- Long-term management requires minimizing sedation to improve patient function and compliance.
Conclusions:
- Treatment of agitation must be tailored to the underlying psychiatric disorder and etiology.
- A shift in pharmacological strategy occurs from acute sedation to functional improvement in remission.
- Minimizing sedation through dosage adjustment or adjunctive therapies is crucial for long-term patient outcomes.